A Historical Cannabis Chapter Reported Both Abnormal and Normal Liver Findings
A historical cannabis chapter presented liver abnormalities in one small series alongside other series without laboratory evidence of liver dysfunction. Keeping both sets of observations prevents the source from being misrepresented as a consistent demonstration of cannabis-caused liver injury.
The reports did not produce one uniform result
Nahas described a small clinical investigation reporting abnormalities among cannabis users. He also cited a hashish-smoking series and another chronic-use series without corresponding laboratory evidence of liver disease.
The chapter identified alcohol co-use in discussing some abnormal findings. These were observational clinical reports, not randomized experiments that isolated cannabis as the only relevant difference.
A clinical observation does not settle attribution
A finding in a person who used cannabis establishes coexistence before it establishes cause. Alcohol exposure, other medical conditions, selection of patients and differences in assessment can affect comparisons.
The null series deserve equal visibility. They do not prove that liver effects are impossible, but they contradict a claim that every historical series found the same abnormality.
The evidence remains historical and limited
Different preparations, small samples and incomplete exposure characterization restrict generalization. The chapter does not supply a current clinical risk estimate or a diagnostic rule for an individual.
Its value here is as an example of conflicting evidence within one source. An accurate analysis reports that conflict and identifies what would be required to distinguish competing explanations, rather than selecting only the result that supports a preferred conclusion.
Related: Separating cannabis exposure and impairment.
Research cited
Gabriel G. Nahas. Marihuana: Toxicity and Tolerance. Historical book chapter, pp. 16–36.
